Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
Oxford Spinout Oxford Semantic Technologies acquired by Samsung ElectronicsArticle links to www.oxionics.com
Oxford Ionics breaks global quantum performance records
Oxford Ionics breaks global quantum performance records
Times Commentary: Science innovation must be at the heart of government action
Times Commentary: Science innovation must be at the heart of government actionArticle links to www.beacontx.com
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene TherapiesArticle links to www.prnewswire.com
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptographyArticle links to www.globenewswire.com
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raisesArticle links to www.businesswire.com
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group

All News

Portfolio NewsOrbit DiscoveryOrbit Discovery and Evergreen Theragnostics expand research collaboration to advance targeted therapeutics developmentPortfolio NewsOrbit DiscoveryOrbit Discovery and Evergreen Theragnostics expand research collaboration to advance targeted therapeutics developmentPortfolio NewsOrbit DiscoverySecarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide TherapeuticsPortfolio NewsOrbit DiscoveryOrano Med and Orbit Discovery enter Collaboration to discover novel targeted radioligand therapies for cancerPortfolio NewsOrbit DiscoveryOrbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticalsPortfolio NewsOrbit DiscoveryOrbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeuticsPortfolio NewsOrbit DiscoveryOrbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugsPortfolio NewsOrbit DiscoveryOrbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologiesPortfolio NewsOrbit DiscoveryOrbit Discovery announces $7.6 million funding to accelerate growth in peptide discovery business